Asset
BL-1021
BioLineRx Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01121380 | phase1 | terminated | 2011-06-01 | 2011-10-01 | BioLineRx, Ltd. | A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 |
FDA applications (0)
This company has no applications containing this asset.